Certified GcMAF Distributor
Worldwide Shipping
Products for Adults, Kids and Infants
The GcMAF Story
GcMAF was first researched and identified by Nobuto Yamamoto in 1991. Since then, it has been the subject of numerous clinical trials worldwide, and has been approved as a food or supplement in several countries. GcMAF is derived from a vitamin D-binding protein, which when modified, may activate macrophages, a type of white blood cell.
Endorsed by Medical Experts
Our products are supported by the expertise of the world's leading experts in GcMAF research, development and use. The MAF Supplies range draw on the work of a number of medical pioneers.
Dr. Toshio Inui
Dr. Toshio Inui
Doctor and worldwide authority on GcMAF treatments
A renowned expert in internal medicine, Dr. Inui has dedicated his career to developing innovative treatments using MAF and other new immunotherapies . With 22 research works and 266 citations into Macrophage activating factors, he is a respected figure in the medical field.
Dr. Galyna Kutsyna
Dr. Galyna Kutsyna
Infectious Disease Specialist and Immunologist
Dr Galyna Kutsyna is an expert in research and treatment of COVID-19, HIV/AIDS, and Pulmonary Tuberculosis. She has co-authored 16 peer reviewed articles detailing her clinical research.With a keen interest in autoimmune disorders, inflammation and other aspects of immunology she is at the forefront of MAF research today.
Dr. Kentaro Kubo
Dr. Kentaro Kubo
Medical doctor, scientist and expert in GcMAF therapies
The Director of a leading cell processing center, Dr. Kubo oversees an immunotherapy facility and has written and researched extensively into the clinical use of GcMAF.
Dr. Akira Takasaki
Dr. Akira Takasaki
M.D, PhD, and Kampo Practitioner
Renowned for his expertise in internal medicine, gerontology, Dementia, and sports medicine, Dr. Takasaki has conducted research into care for the elderly. With a passion for music, he's also known as the "Tenor Doctor."
